LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 80 filers reported holding LYELL IMMUNOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.02 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $586,777 | -53.8% | 399,168 | 0.0% | 0.06% | -42.9% |
| Q2 2023 | $1,269,354 | +3178.9% | 399,168 | +2333.4% | 0.10% | +3166.7% |
| Q1 2023 | $38,713 | +67817.5% | 16,404 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $57 | -100.0% | 16,404 | 0.0% | 0.01% | -58.3% |
| Q3 2022 | $120,000 | +12.1% | 16,404 | 0.0% | 0.01% | +9.1% |
| Q2 2022 | $107,000 | -15.7% | 16,404 | 0.0% | 0.01% | +10.0% |
| Q1 2022 | $127,000 | 0.0% | 16,404 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $127,000 | – | 16,404 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |